Skip to main content
Fig. 3 | Orphanet Journal of Rare Diseases

Fig. 3

From: Genetic, clinical and biochemical characterization of a large cohort of patients with hyaline fibromatosis syndrome

Fig. 3

Unsupervised analysis of all 4978 compounds that met our detection criteria as regards quality and quantity upon comparative analysis of samples from HFS (in red) and control samples (in white). (a) Principal component analysis separates the majority of HFS patient samples from controls samples, and this is largely based on principal component 1. (b) Hierarchical clustering confirms that control samples are biochemically distinct from patient samples

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172